The global glutamic acid market size accounted for USD 14.10 billion in 2024, grew to USD 14.93 billion in 2025 and is predicted to surpass around USD 25.01 billion by 2034, representing a healthy CAGR of 5.90% between 2024 and 2034.
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Glutamic Acid Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Glutamic Acid Market, by Application Type, 2024-2034
8.1.1. Food & Beverages
8.1.1.1. Market Revenue and Forecast (2021-2034)
8.1.2. Pharmaceuticals
8.1.2.1. Market Revenue and Forecast (2021-2034)
8.1.3. Animal Feed
8.1.3.1. Market Revenue and Forecast (2021-2034)
8.1.4. Others
8.1.4.1. Market Revenue and Forecast (2021-2034)
9.1. North America
9.1.1. Market Revenue and Forecast, by Application (2021-2034)
9.1.2. U.S.
9.1.3. Rest of North America
9.1.3.1. Market Revenue and Forecast, by Application (2021-2034)
9.2. Europe
9.2.1. Market Revenue and Forecast, by Application (2021-2034)
9.2.2. UK
9.2.2.1. Market Revenue and Forecast, by Application (2021-2034)
9.2.3. France
9.2.3.1. Market Revenue and Forecast, by Application (2021-2034)
9.2.4. Rest of Europe
9.2.4.1. Market Revenue and Forecast, by Application (2021-2034)
9.3. APAC
9.3.1. Market Revenue and Forecast, by Application (2021-2034)
9.3.2. India
9.3.2.1. Market Revenue and Forecast, by Application (2021-2034)
9.3.3. China
9.3.3.1. Market Revenue and Forecast, by Application (2021-2034)
9.3.4. Japan
9.3.4.1. Market Revenue and Forecast, by Application (2021-2034)
9.3.5. Rest of APAC
9.3.5.1. Market Revenue and Forecast, by Application (2021-2034)
9.4. MEA
9.4.1. Market Revenue and Forecast, by Application (2021-2034)
9.4.2. GCC
9.4.2.1. Market Revenue and Forecast, by Application (2021-2034)
9.4.3. North Africa
9.4.3.1. Market Revenue and Forecast, by Application (2021-2034)
9.4.4. South Africa
9.4.4.1. Market Revenue and Forecast, by Application (2021-2034)
9.4.5. Rest of MEA
9.4.5.1. Market Revenue and Forecast, by Application (2021-2034)
9.5. Latin America
9.5.1. Market Revenue and Forecast, by Application (2021-2034)
9.5.2. Brazil
9.5.2.1. Market Revenue and Forecast, by Application (2021-2034)
9.5.3. Rest of LATAM
9.5.3.1. Market Revenue and Forecast, by Application (2021-2034)
10.1. Ajinomoto Co., Inc.
10.1.1. Company Overview
10.1.2. Application Offerings
10.1.3. Financial Performance
10.1.4. Recent Initiatives
10.2. Akzo Nobel N.V.
10.2.1. Company Overview
10.2.2. Application Offerings
10.2.3. Financial Performance
10.2.4. Recent Initiatives
10.3. Evonik Industries AG
10.3.1. Company Overview
10.3.2. Application Offerings
10.3.3. Financial Performance
10.3.4. Recent Initiatives
10.4. Sichuan Tongsheng Amino acid Co., Ltd.
10.4.1. Company Overview
10.4.2. Application Offerings
10.4.3. Financial Performance
10.4.4. Recent Initiatives
10.5. KYOWA HAKKO BIO CO., LTD.
10.5.1. Company Overview
10.5.2. Application Offerings
10.5.3. Financial Performance
10.5.4. Recent Initiatives
10.6. Ottokemi
10.6.1. Company Overview
10.6.2. Application Offerings
10.6.3. Financial Performance
10.6.4. Recent Initiatives
10.7. Hefei TNJ Chemical Industry Co., Ltd.
10.7.1. Company Overview
10.7.2. Application Offerings
10.7.3. Financial Performance
10.7.4. Recent Initiatives
10.8. Suzhou Yuanfang Chemical Co., Ltd.
10.8.1. Company Overview
10.8.2. Application Offerings
10.8.3. Financial Performance
10.8.4. Recent Initiatives
10.9. Global Bio-chem Technology Group Company Limited
10.9.1. Company Overview
10.9.2. Application Offerings
10.9.3. Financial Performance
10.9.4. Recent Initiatives
10.10. Ningxia Yipin Biological Technology Co., Ltd.
10.10.1. Company Overview
10.10.2. Application Offerings
10.10.3. Financial Performance
10.10.4. Recent Initiatives
11.1. Primary Research
11.2. Secondary Research
11.3. Assumptions
12.1. About Us
12.2. Glossary of Terms
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Report Description
Get a Sample